Coda Biotherapeutics is a biotechnology company which provides a chemogenetic platform that aims to control the activity of cells to treat a disease. The Company develops a chemogenetic treatment to modulate neuronal activity. Its main product includes non-native safe, orally bioavailable drugs which activate or silence the targeted neurons, depending on the receptor used. The drugs allow curing neuropathic pains, epilepsy, movement disorders, and other nervous system disorders.